戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 f which 10% were treated with an epinephrine autoinjector.
2 nfident in knowing when to use an adrenaline autoinjector.
3           Many with wheeze did not use their autoinjector.
4 eously from a ready-to-use formulation in an autoinjector.
5 56 adults) had a prescription for adrenaline autoinjector.
6 amics following adrenaline administration by autoinjector.
7 feedback therapy before using the adrenaline autoinjector.
8 y of life compared to carrying an adrenaline autoinjector.
9 eactions with antihistamines and epinephrine autoinjectors.
10 of supporting measures and lack of antidotal autoinjectors.
11 y, of whom 38 288 were prescribed adrenaline autoinjectors.
12 naphylaxis knowledge and competence in using autoinjectors.
13 ) and were more likely to use an epinephrine autoinjector (48% vs 35%, P = .01).
14 laxis treatment, and provision of adrenaline autoinjectors (AAI) has become a standard of care for pe
15 as shown patients commonly misuse adrenaline autoinjectors (AAI).
16       Although paramedics can use adrenaline autoinjectors (AAIs) during their duties, the actual con
17       Patients already prescribed adrenaline autoinjectors (AAIs) for anaphylaxis were examined with
18                     The number of adrenaline autoinjectors activated per 1000 students at risk of ana
19                          However, adrenaline autoinjector activation has remained fairly stable despi
20                                     Although autoinjectors allow faster access to epinephrine for ana
21 c children who were prescribed an adrenaline autoinjector and to assess whether it was used appropria
22    Additionally, authors discuss epinephrine autoinjectors and the various routes of epinephrine admi
23  to be at risk for suboptimal treatment when autoinjectors are used.
24  (at least for 2 h), and carry an adrenaline autoinjector at all times.
25 proportion of patients prescribed adrenaline autoinjectors by English Index of Multiple Deprivation (
26                               No epinephrine autoinjectors contain an optimal dose for infants weighi
27 e risk of severe anaphylaxis, development of autoinjectors containing a 0.1-mg epinephrine dose suita
28 rers are unsure when to use their adrenaline autoinjectors, contributing to a low quality of life and
29 laxis in teenagers and adults; however, most autoinjectors deliver a maximum 300 mug dose.
30                                 The specific autoinjector device seems to be the most important deter
31 s to generate pharmacokinetic data for these autoinjector devices.
32 netic data should be provided for adrenaline autoinjector devices.
33 so less likely to have filled an epinephrine autoinjector (EAI) prescription or visited an allergist/
34 s at risk should always carry an epinephrine autoinjector (EAI).
35 d March 2017 and were prescribed epinephrine autoinjector (EpiPen((R))) for treatment were enrolled.
36 ction (VCD) in a child to whom an adrenaline autoinjector (Epipen((R))) had been prescribed and frequ
37  (84% of patients were prescribed adrenaline autoinjectors following EAACI guidelines) and outside th
38 relies on allergen avoidance and epinephrine autoinjector for rescue treatment in patients at risk of
39 ry an emergency kit containing an adrenaline autoinjector, H1 -antihistamines, and corticosteroids de
40 vels and the annual usage rate of adrenaline autoinjectors in the school setting relative to the numb
41 me time period, prescriptions for adrenaline autoinjectors increased by 336% (estimated rate ratio 1.
42 ction, and reimbursement/availability of the autoinjector influence physician's decision to prescribe
43               These results suggest that the autoinjector is often not used appropriately after presc
44            Based on limited data, the Mark 1 autoinjector kit (Meridian Medical Technologies, Columbi
45                   Newer models of adrenaline autoinjectors may slightly increase the proportion of pe
46  41 patients with anaphylaxis who used their autoinjector needed another dose of adrenaline.
47 the study medication by either intramuscular autoinjector or intravenous infusion.
48 ospital system, with low rates of adrenaline autoinjector prescription in those with previous anaphyl
49                                   Adrenaline autoinjectors prescription was less common in those resi
50 y, and probable food allergy with adrenaline autoinjectors prescription.
51  included fear of use, unavailability of the autoinjector, prior improvement with use of an oral anti
52 f anaphylaxis, and those carrying adrenaline autoinjectors scored higher and had lower QOL.
53 ture of LTP allergy, the need for adrenaline autoinjectors should always be considered.
54 here has been a debate about when adrenaline autoinjectors should be prescribed and how many should b
55 e subcutaneous injection, preferably with an autoinjector that can be used directly by patients.
56 agent antidotes are available in prepackaged autoinjectors that can be delivered rapidly following an
57 ommended with the availability of adrenaline autoinjectors to patients in the community.
58               Similarly, rates of adrenaline autoinjector usage in the school environment have yet to
59  as emergency department visits, epinephrine autoinjector use, and severe reactions, were measured ac
60 more effective guidance on proper adrenaline autoinjector use.
61                                An adrenaline autoinjector was prescribed to 139 food allergic childre
62                                An adrenaline autoinjector was used by 41 (16.7%, 95% CI: 11.7-21.3) p
63 hylaxis after the prescription; however, the autoinjector was used in only six (25%) of those cases.
64 on were analyzed, as was whether and how the autoinjector was used.
65 c children who were prescribed an adrenaline autoinjector were investigated.
66 st 1747 (3.7%) of those prescribed a 150 mug autoinjector were likely to exceed the weight threshold
67    Thereafter, she did not use an adrenaline autoinjector when symptoms appeared; instead, she would
68 k of anaphylaxis be prescribed 2 epinephrine autoinjectors, which they should carry at all times.
69 of adult formulated atropine and pralidoxime autoinjectors will deliver doses above current recommend
70       Patients should possess an epinephrine autoinjector with an anaphylaxis self-management plan.